India suggests use of asthma drug to block crucial SARS-CoV-2 protein - BSA bureau

4/27/2022 12:00:00 AM3 yearsago
Asthma drug can block crucial SARS-CoV-2 protein
The study is published by the researchers at the Indian Institute of Science (IISc) A drug used to treat asthma and allergies can bind to and block a crucial protein produced by the virus SARS-CoV-… [+1313 chars]
full article...